Reduced type I collagen utilization: A pathogenic mechanism in COL5A1 haplo-insufficient Ehlers-Danlos syndrome

Richard J. Wenstrup, Jane B. Florer, William G. Cole, Marcia C. Willing, David E. Birk

Research output: Contribution to journalArticle

42 Scopus citations

Abstract

To examine mechanisms by which reduced type V collagen causes weakened connective tissues in the Ehlers-Danlos syndrome (EDS), we examined matrix deposition and collagen fibril morphology in long-term dermal fibroblast cultures. EDS cells with COL5A1 haplo-insufficiency deposited less than one-half of hydroxyproline as collagen compared to control fibroblasts, though total collagen synthesis rates are near-normal because type V collagen represents a small fraction of collagen synthesized. Cells from patients with osteogenesis imperfecta (OI) and haplo-insufficiency for proα1(I) chains of type I collagen also incorporated about one-half the collagen as controls, but this amount was proportional to their reduced rates of total collagen synthesis. Collagen fibril diameter was inversely proportional to type V/type I collagen ratios (EDS > control >OI). However, a reduction of type V collagen, in the EDS derived cells, was associated with the assembly of significantly fewer fibrils compared to control and Ol cells. These data indicate that in cell culture, the quantity of collagen fibrils deposited in matrix is highly sensitive to reduction in type V collagen, far out of proportion to type V collagen's contribution to collagen mass.

Original languageEnglish
Pages (from-to)113-124
Number of pages12
JournalJournal of cellular biochemistry
Volume92
Issue number1
DOIs
StatePublished - Dec 1 2004
Externally publishedYes

Keywords

  • Collagen
  • Ehlers-Danlos
  • Extracellular matrix
  • Type V

Fingerprint Dive into the research topics of 'Reduced type I collagen utilization: A pathogenic mechanism in COL5A1 haplo-insufficient Ehlers-Danlos syndrome'. Together they form a unique fingerprint.

Cite this